Mao reports the results of the responses of 63% (255) of 402 Chinese geneticists who participated in a national survey designed to identify their views on the ethical issues involved in genetic testing and screening. The Chinese geneticists differ in almost every area from their North American and west European counterparts, and the degree of polarisation may at first seem astonishing to geneticists working in developed countries who have a fundamental objection to eugenics. The Chinese respondents strongly favoured offering genetic testing at work for α1-antitrypsin deficiency (95%) and for genetic predisposition to heart disease, cancer, and diabetes in executives (94%). A total of 86% wanted …